Cosmos Health EBITDA per Share

What does Cosmos Health do? Cosmos Health Inc generates revenue through the importation, exportation, distribution, and sale of branded pharmaceuticals, over-the-counter medicines, and generic pharmaceuticals. The company leverages its subsidiary Amplerissimo Ltd., which provides data mining, statistical data analysis, research, and consulting services including credit risk analysis, marketing management, and business management software consulting. SkyPharm S.A., a subsidiary of Amplerissimo, trades branded and generic pharmaceutical products across the European Union member states, contributing to the company's revenue streams. Clients include sectors requiring pharmaceutical distribution, consulting services, and EU market access for medicines. Amplerissimo's services target businesses needing data-driven insights, credit management, and strategic consulting, while SkyPharm serves the European pharmaceutical market with a focus on branded and generic products. The company's revenue model combines direct product sales with specialized consulting services, catering to both domestic and international clients in the pharmaceutical industry. This dual approach allows Cosmos Health Inc to address diverse market needs through its subsidiaries and core operations. The firm's primary buyers are pharmaceutical distributors, healthcare providers, and businesses seeking consulting services for market expansion, data analysis, and credit management. Amplerissimo's consulting services support clients in sectors requiring strategic planning, while SkyPharm's trading activities serve EU-based pharmaceutical companies and distributors. Cosmos Health Inc's revenue is derived from product sales and service contracts, with no mention of additional revenue streams beyond the described operations. Cosmos Health is one of the most popular companies on Eulerpool.